J Korean Neurosurg Soc.
1993 Feb;22(2):252-260.
Clinical Analysis of Stereotactic Brachytherapy with High-Activity Iridium-192 Sources for Treatment of Malignant Astrocytomas
- Affiliations
-
- 1Department of Neurosurgery, School of Medicine, Keimyung University, Taegu, Korea.
- 2Department of Therapeutic Radiology, School of Medicine, Keimyung University, Taegu, Korea.
Abstract
- Interstitial irradiation using high-activity Iridium-192 sources was studied clinically to treat supratentorial malignant astrocytomas(including glioblastoma multifrome). As of 1988, in attempt to define the efficacy of this technique in patients with more extensive disease, we treated patients less rigid selection criteria. 15 eligible patients have been approached and ten have accepted randomization for follow-up study over two years. Pathology was anaplastic astrocytoma in 5 patients, glioblastoma multiforme in 5 patients. Mean survival of patients treated with this procedure was 18.4 months. Continued investigation will determine which patient may benefit from this techique.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Stereotatic Interstitial Brachytheraoy with Iridium-192 in the Treatment of Brain Tumors-Report of Intial Experience
- Clinical Analysis of Brachytherapy Using Iodine-125 and Iridium-192 for the Treatment of Intracranial Malignant Gliomas
- Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources
- Brachytherapy in the Treatment of Head and Neck Cancer
- Development and Application of Ir-192 Brachytherapy Source in Korea
